Familial thrombophilia and idiopathic intracranial hypertension

Neuro-Ophthalmology

Volumn 25, Issue 3, 2001, Pages 135-141

  Backhouse, O C ^a   Johnson, M ^a   Jamieson, D R ^a   Menage, M J ^a   Goulding, P J ^a   McVerry, B A ^a   Cawthray, N ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Antiphospholipid antibodies; Idiopathic intracranial hypertension; Obesity; Thrombophilia; Venous sinus thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN S;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; INTRACRANIAL HYPERTENSION; LIFESTYLE; MALE; OBESITY; ORAL CONTRACEPTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; THROMBOPHILIA;

EID: 0035659547     PISSN: 01658107     EISSN: None     Source Type: Journal    
DOI: 10.1076/noph.25.3.135.7127     Document Type: Article

References (29)

1. Whence Pseudotumour cerebri?
2. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions
3. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia
4. Cerebral sinus thrombosis and oral contraceptives
5. Congenital protein C deficiency and sagital sinus thrombosis causing isolated intracranial hypertension
6. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension
7. Anticardolipin antibodies are frequently present in patients with idiopathic intracranial hypertension
8. Factor V Leiden mutation in association with idiopathic intracranial hypertension
9. Benign intracranial hypertension: A non-thrombotic complication of the primary antiphospholipid syndrome?
10. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria
11. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
12. Symptoms and disease associations in idiopathic intracranial hypertension (Pseudotumour cerebri): A case-control study
13. The search for causes of Pseudotumour cerebri: A preliminary case-control study
14. The 'primary' antiphospholipid syndrome: Major clinical and serological features
15. The prevalance of anticardolipin antibodies in a healthy elderly population and its association with antinuclear antibodies
16. Systemic lupus erythematosus: Emerging concepts. Part 2. Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality and pathogenesis
17. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies - Prevalence and significance
18. Pseudotumour cerebri in systemic lupus erythematosus
19. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood
20. Antiphospholipid antibodies and thrombotic predisposition: Underlying pathogenic mechanisms
21. Characterisation and specificity of antiendothelial cell membrane antibodies and their relationship to thrombosis in the primary antiphospholipid syndrome
22. The management of thrombosis in the antiphospholipid syndrome
23. Idiopathic intracranial hypertension and anticardolipin antibodies
24. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twin
25. Minocycline treatment and Pseudotumour cerebri syndrome
26. Identification of the estrogen product of extraglandular aromatization of plasma androstenedione
27. Comparative studies of 30g ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets
28. Renewed interest in haemostasis changes induced by oral contraceptives (Ocs)
29. Idiopathic intracranial hypertension